These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15113282)

  • 1. Management of dyschromias in ethnic skin.
    Halder RM; Richards GM
    Dermatol Ther; 2004; 17(2):151-7. PubMed ID: 15113282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postinflammatory hyperpigmentation in patients with skin of color.
    Shokeen D
    Cutis; 2016 Jan; 97(1):E9-E11. PubMed ID: 26919365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new formula for depigmenting human skin.
    Kligman AM; Willis I
    Arch Dermatol; 1975 Jan; 111(1):40-8. PubMed ID: 1119822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical treatment of hyperpigmentation disorders.
    Rendon M; Horwitz S
    Ann Dermatol Venereol; 2012 Dec; 139 Suppl 4():S153-8. PubMed ID: 23522631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycolic acid peels for postinflammatory hyperpigmentation in black patients. A comparative study.
    Burns RL; Prevost-Blank PL; Lawry MA; Lawry TB; Faria DT; Fivenson DP
    Dermatol Surg; 1997 Mar; 23(3):171-4; discussion 175. PubMed ID: 9145958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further enhancement of facial appearance with a hydroquinone skin care system plus tretinoin in patients previously treated with botulinum toxin Type A.
    Schlessinger J; Kenkel J; Werschler P
    Aesthet Surg J; 2011 Jul; 31(5):529-39. PubMed ID: 21719866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a kojic acid, emblica extract, and glycolic acid formulation compared with hydroquinone 4% for skin lightening.
    Draelos ZD; Yatskayer M; Bhushan P; Pillai S; Oresajo C
    Cutis; 2010 Sep; 86(3):153-8. PubMed ID: 21049734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A method for maintaining the clinical results of 4% hydroquinone and 0.025% tretinoin with a cosmeceutical formulation.
    Draelos ZD; Raab S; Yatskayer M; Chen N; Krol Y; Oresajo C
    J Drugs Dermatol; 2015 Apr; 14(4):386-90. PubMed ID: 25844613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cosmetic color improvement of the nipple-areola complex by optimal use of tretinoin and hydroquinone.
    Yoshimura K; Momosawa A; Watanabe A; Sato K; Matsumoto D; Aiba E; Harii K; Yamamoto T; Aoyama T; Iga T
    Dermatol Surg; 2002 Dec; 28(12):1153-7; discussion 1158. PubMed ID: 12472496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience with a strong bleaching treatment for skin hyperpigmentation in Orientals.
    Yoshimura K; Harii K; Aoyama T; Iga T
    Plast Reconstr Surg; 2000 Mar; 105(3):1097-108; discussion 1109-10. PubMed ID: 10724272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acne in ethnic skin: special considerations for therapy.
    Callender VD
    Dermatol Ther; 2004; 17(2):184-95. PubMed ID: 15113286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dyspigmentation, skin physiology, and a novel approach to skin lightening.
    Draelos Z; Dahl A; Yatskayer M; Chen N; Krol Y; Oresajo C
    J Cosmet Dermatol; 2013 Dec; 12(4):247-53. PubMed ID: 24305422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloidosis cutis dyschromica: a rare pigmentary disorder.
    Garg T; Chander R; Jabeen M; Barara M; Mittal K; Jain M; Puri V
    J Cutan Pathol; 2011 Oct; 38(10):823-6. PubMed ID: 21592180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cosmetic and dermatology: bleaching creams.
    Engasser PG; Maibach HI
    J Am Acad Dermatol; 1981 Aug; 5(2):143-7. PubMed ID: 7021611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated treatment protocols for melasma and acquired dermal melanocytosis.
    Yoshimura K; Sato K; Aiba-Kojima E; Matsumoto D; Machino C; Nagase T; Gonda K; Koshima I
    Dermatol Surg; 2006 Mar; 32(3):365-71. PubMed ID: 16640680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4-n-butylresorcinol, a highly effective tyrosinase inhibitor for the topical treatment of hyperpigmentation.
    Kolbe L; Mann T; Gerwat W; Batzer J; Ahlheit S; Scherner C; Wenck H; Stäb F
    J Eur Acad Dermatol Venereol; 2013 Jan; 27 Suppl 1():19-23. PubMed ID: 23205541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris in an Asian Population.
    Han G; Armstrong AW; Desai SR; Guenin E
    J Drugs Dermatol; 2019 Sep; 18(9):910-916. PubMed ID: 31524347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical agents used in the management of hyperpigmentation.
    Halder RM; Richards GM
    Skin Therapy Lett; 2004; 9(6):1-3. PubMed ID: 15334278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of hydroquinone (2%) versus tretinoin (0.025%) as adjunct topical agents for chemical peeling in patients of melasma.
    Nanda S; Grover C; Reddy BS
    Dermatol Surg; 2004 Mar; 30(3):385-8; discussion 389. PubMed ID: 15008866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefits of using a hydroquinone/tretinoin skin care system in patients undergoing intense pulsed light therapy for photorejuvenation: a placebo-controlled study.
    Woodhall KE; Goldman MP; Gold MH; Biron J
    J Drugs Dermatol; 2009 Sep; 8(9):862-7. PubMed ID: 19746679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.